rs41562513

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000249.4(MLH1):​c.1558+14G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0384 in 1,613,872 control chromosomes in the GnomAD database, including 1,440 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★★).

Frequency

Genomes: 𝑓 0.053 ( 289 hom., cov: 32)
Exomes 𝑓: 0.037 ( 1151 hom. )

Consequence

MLH1
NM_000249.4 intron

Scores

2

Clinical Significance

Benign reviewed by expert panel U:1B:24

Conservation

PhyloP100: -0.851

Publications

16 publications found
Variant links:
Genes affected
MLH1 (HGNC:7127): (mutL homolog 1) The protein encoded by this gene can heterodimerize with mismatch repair endonuclease PMS2 to form MutL alpha, part of the DNA mismatch repair system. When MutL alpha is bound by MutS beta and some accessory proteins, the PMS2 subunit of MutL alpha introduces a single-strand break near DNA mismatches, providing an entry point for exonuclease degradation. The encoded protein is also involved in DNA damage signaling and can heterodimerize with DNA mismatch repair protein MLH3 to form MutL gamma, which is involved in meiosis. This gene was identified as a locus frequently mutated in hereditary nonpolyposis colon cancer (HNPCC). [provided by RefSeq, Aug 2017]
MLH1 Gene-Disease associations (from GenCC):
  • Lynch syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet, G2P
  • Lynch syndrome 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp
  • Muir-Torre syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, G2P, Orphanet
  • mismatch repair cancer syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, G2P, ClinGen
  • Lynch syndrome 1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • ovarian cancer
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • malignant pancreatic neoplasm
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • rhabdomyosarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • prostate cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • breast cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
  • hereditary breast carcinoma
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 3-37028946-G-A is Benign according to our data. Variant chr3-37028946-G-A is described in ClinVar as Benign. ClinVar VariationId is 36541.Status of the report is reviewed_by_expert_panel, 3 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0967 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000249.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MLH1
NM_000249.4
MANE Select
c.1558+14G>A
intron
N/ANP_000240.1P40692-1
MLH1
NM_001354628.2
c.1558+14G>A
intron
N/ANP_001341557.1A0A087WX20
MLH1
NM_001354629.2
c.1459+14G>A
intron
N/ANP_001341558.1A0AAQ5BGZ2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MLH1
ENST00000231790.8
TSL:1 MANE Select
c.1558+14G>A
intron
N/AENSP00000231790.3P40692-1
MLH1
ENST00000456676.7
TSL:1
c.1558+14G>A
intron
N/AENSP00000416687.3H0Y818
MLH1
ENST00000413740.2
TSL:1
c.1558+14G>A
intron
N/AENSP00000416476.2H0Y806

Frequencies

GnomAD3 genomes
AF:
0.0533
AC:
8104
AN:
152074
Hom.:
287
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0989
Gnomad AMI
AF:
0.0121
Gnomad AMR
AF:
0.0334
Gnomad ASJ
AF:
0.0294
Gnomad EAS
AF:
0.0187
Gnomad SAS
AF:
0.0191
Gnomad FIN
AF:
0.0387
Gnomad MID
AF:
0.0570
Gnomad NFE
AF:
0.0392
Gnomad OTH
AF:
0.0502
GnomAD2 exomes
AF:
0.0366
AC:
9200
AN:
251280
AF XY:
0.0355
show subpopulations
Gnomad AFR exome
AF:
0.100
Gnomad AMR exome
AF:
0.0197
Gnomad ASJ exome
AF:
0.0276
Gnomad EAS exome
AF:
0.0215
Gnomad FIN exome
AF:
0.0357
Gnomad NFE exome
AF:
0.0406
Gnomad OTH exome
AF:
0.0370
GnomAD4 exome
AF:
0.0368
AC:
53820
AN:
1461678
Hom.:
1151
Cov.:
32
AF XY:
0.0361
AC XY:
26230
AN XY:
727156
show subpopulations
African (AFR)
AF:
0.101
AC:
3396
AN:
33474
American (AMR)
AF:
0.0213
AC:
953
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0252
AC:
659
AN:
26136
East Asian (EAS)
AF:
0.0181
AC:
718
AN:
39696
South Asian (SAS)
AF:
0.0189
AC:
1626
AN:
86254
European-Finnish (FIN)
AF:
0.0357
AC:
1903
AN:
53374
Middle Eastern (MID)
AF:
0.0397
AC:
229
AN:
5768
European-Non Finnish (NFE)
AF:
0.0378
AC:
42047
AN:
1111864
Other (OTH)
AF:
0.0379
AC:
2289
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
2731
5461
8192
10922
13653
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1594
3188
4782
6376
7970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0534
AC:
8131
AN:
152194
Hom.:
289
Cov.:
32
AF XY:
0.0529
AC XY:
3932
AN XY:
74380
show subpopulations
African (AFR)
AF:
0.0993
AC:
4120
AN:
41510
American (AMR)
AF:
0.0334
AC:
510
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.0294
AC:
102
AN:
3470
East Asian (EAS)
AF:
0.0187
AC:
97
AN:
5180
South Asian (SAS)
AF:
0.0189
AC:
91
AN:
4818
European-Finnish (FIN)
AF:
0.0387
AC:
410
AN:
10588
Middle Eastern (MID)
AF:
0.0646
AC:
19
AN:
294
European-Non Finnish (NFE)
AF:
0.0392
AC:
2666
AN:
68024
Other (OTH)
AF:
0.0497
AC:
105
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
379
758
1137
1516
1895
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
84
168
252
336
420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0435
Hom.:
126
Bravo
AF:
0.0556
Asia WGS
AF:
0.0240
AC:
83
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
9
not specified (9)
-
1
3
Colorectal cancer, hereditary nonpolyposis, type 2 (4)
-
-
3
Lynch syndrome (3)
-
-
3
not provided (3)
-
-
2
Hereditary cancer-predisposing syndrome (2)
-
-
1
Carcinoma of colon (1)
-
-
1
Hereditary nonpolyposis colorectal neoplasms (1)
-
-
1
Lynch syndrome 1 (1)
-
-
1
Muir-Torré syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
0.20
DANN
Benign
0.44
PhyloP100
-0.85
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
Splicevardb
1.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41562513; hg19: chr3-37070437; COSMIC: COSV51618587; COSMIC: COSV51618587; API